We set out to investigate ERβ expression in DLBCL cell lines and primary DLBCL as well as the potential effect of tamoxifen in wild-type and ERβ knock-out DLBCL cell lines and a xenograft lymphoma model. This evidence concerns the gene ESR2 and lymphoma.